Members |
targetComponentId |
Testes sample |
Tissue specimen from testis |
Testicular hormone |
Androgen receptor agonist (disposition) |
Testicular hormone |
Androgen receptor agonist |
Testicular hypofunction due to defect in adrenocortical hormone synthesis |
Testicular hypofunction due to defect in adrenocortical hormone synthesis |
Testis implantation |
Procedure on testis |
Testis: [undescended, bilateral] or [bilateral maldescent] |
Undescended testes - bilateral |
Testis: [undescended, unilateral] or [unilateral maldescent] |
Undescended left testicle |
Testis: [undescended, unilateral] or [unilateral maldescent] |
Undescended right testicle |
Testosterone 100mg injection 2mL |
Testosterone-containing product in parenteral dose form |
Testosterone 100mg injection 2mL |
Testosterone-containing product in parenteral dose form |
Testosterone 2.5mg/24hours transdermal patch |
Testosterone 104.167 microgram/hour prolonged-release transdermal patch |
Testosterone 2.5mg/day |
Testosterone 104.167 microgram/hour prolonged-release transdermal patch |
Testosterone 250mg/1mL injection |
Testosterone enantate 250 mg/mL solution for injection |
Testosterone 250mg/1mL injection |
Testosterone enantate 250 mg/mL solution for injection |
Testosterone 328mg |
Testosterone 208.333 microgram/hour prolonged-release transdermal patch |
Testosterone 5mg/24hours transdermal patch |
Testosterone 208.333 microgram/hour prolonged-release transdermal patch |
Testosterone 5mg/day patch |
Testosterone 208.333 microgram/hour prolonged-release transdermal patch |
Testosterone 6mg/24hours transdermal patch |
Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Testosterone 6mg/day |
Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
Testosterone 6mg/day patch |
Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
énanthate de testostérone 250 mg/mL, ampoule de 1 mL de solution injectable |
Testosterone enantate 250 mg/mL solution for injection |
Testosterone propionate 50mg/mL injection solution 2mL ampule |
Testosterone propionate 50 mg/mL solution for injection |
Testosterone undecanoate 250mg/mL injection solution 4mL ampule |
Testosterone undecanoate 250 mg/mL solution for injection |
Tet/low dose dipther vaccine (& vaccination) |
Vaccine product containing only Clostridium tetani and low dose Corynebacterium diphtheriae antigens (medicinal product) |
Tetanus + polio vaccination (& [postschool]) |
Administration of poliomyelitis and tetanus vaccine |
Tetanus + polio vaccination (& [postschool]) |
Post-school administration of vaccine product containing only Clostridium tetani and Human poliovirus antigens (procedure) |
anatoxines tétanique et diphtérique |
Adult vaccine product containing only Clostridium tetani and Corynebacterium diphtheriae toxoids (medicinal product) |
dT diphtérie + tétanos adulte non spécifié |
Vaccine product containing only Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
Tetanus antitoxin |
Tetanus antitoxin (substance) |
Tetanus antitoxin |
Tetanus immunoglobulin (substance) |
tétanos compliquant un avortement |
Induced termination of pregnancy complicated by tetanus |
Tetanus immune globulin huma 250units injection |
Product containing precisely human tetanus immunoglobulin 250 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tetanus immune globulin huma 250units injection solution 10mL vial |
Product containing precisely human tetanus immunoglobulin 250 unit/1 milliliter conventional release solution for injection (clinical drug) |
Tetanus immune globulin huma 250units injection solution 1mL vial |
Product containing precisely human tetanus immunoglobulin 250 unit/1 milliliter conventional release solution for injection (clinical drug) |
flacon d'une solution pour perfusion de 2500 UI d'immunoglobuline antitétanique |
Product containing only human tetanus immunoglobulin in parenteral dose form (medicinal product form) |
seringue préremplie avec solution injectable de 250 UI d'immunoglobuline antitétanique |
Product containing precisely human tetanus immunoglobulin 250 unit/1 milliliter conventional release solution for injection (clinical drug) |
flacon d'une solution injectable de 250 UI d'immunoglobuline antitétanique |
Product containing precisely human tetanus immunoglobulin 250 unit/1 milliliter conventional release solution for injection (clinical drug) |
anatoxine tétanique |
Vaccine product containing Clostridium tetani antigen (medicinal product) |
anatoxine tétanique, adsorbé |
Vaccine product containing Clostridium tetani antigen (medicinal product) |
Tetanus toxoid extract |
Vaccine product containing only Clostridium tetani toxoid antigen (medicinal product) |
Tetanus toxoid fluid |
Vaccine product containing Clostridium tetani antigen (medicinal product) |
ampoule de 0,5 mL d'une solution injectable de 20 U/mL d'anatoxine tétanique adsorbée |
Vaccine product containing only Clostridium tetani toxoid antigen adsorbed (medicinal product) |
T tétanos non spécifié |
Vaccine product containing Clostridium tetani antigen (medicinal product) |
Vaccin tétanos |
Vaccine product containing Clostridium tetani antigen (medicinal product) |
Tetanus+polio vaccination (& [postschool] or [oral]) |
Post-school administration of vaccine product containing only Clostridium tetani and Human poliovirus antigens (procedure) |
Tetanus+polio vaccination (& [postschool] or [oral]) |
Post-school administration of vaccine product containing only Clostridium tetani and Human poliovirus antigens (procedure) |
Tetanus+polio vaccination (& [postschool] or [oral]) |
Administration of poliomyelitis and tetanus vaccine |
Tetany |
Acquired claw hand |
Tetany |
Tetany |
Tetany |
Carpopedal spasm |
Tetrachloroethane |
1,1,2,2-tetrachloroethane (substance) |
Tetrachloroethane |
Tetrachloroethane |
cosyntrophine 250 microgrammes/1mL pour injection |
Product containing precisely tetracosactide acetate 250 microgram/1 milliliter conventional release solution for injection (clinical drug) |
Tetracycline (class of antibiotic, substance) (product) |
Product containing tetracycline (medicinal product) |
Tetracyclines [skin] |
Product containing tetracycline (medicinal product) |
Tetracyclines [systemic] |
Product containing tetracycline (medicinal product) |
Tetracyclines group allergy |
Allergy to tetracycline (finding) |
Tetralogy of Fallot: [unspecified] or [ventricular septal defect in] or [dextraposition of aorta in] |
Dextraposition of aorta in Fallot's tetralogy |
Tetralogy of Fallot: [unspecified] or [ventricular septal defect in] or [dextraposition of aorta in] |
Ventricular septal defect in Fallot's tetralogy |
Tetrameres species |
Tetrameres |
Textile dye or resin |
Textile resin |
Textile dye or resin |
Textile dye |
Textile: [linking machinist] or [linker] |
Textile linking machinist |
Textile: [linking machinist] or [linker] |
Textile linking machinist |
Textile: [linking machinist] or [linker] |
Linker - textile |
Textile: [linking machinist] or [linker] |
Linker - textile |
Textile: [repairer] or [darner] |
Textile repairer |
Textile: [repairer] or [darner] |
Darner - textile |
Textile: [repairer] or [darner] |
Darner - textile |
Textile: [repairer] or [darner] |
Textile repairer |
Thalamo-olivary fibers |
Structure of central tegmental tract |
Thalamoolivary fibers |
Structure of central tegmental tract |
Thalamostriate vein and its tributaries |
Entire thalamostriate vein |
Thalamostriate vein and its tributaries |
Structure of thalamostriate vein |
Thalassaemia major: [NEC] or [Cooley's anaemia] |
Homozygous beta thalassemia |
Thalassemia minor |
Heterozygous thalassemia |
Thalassemia minor |
Beta thalassaemia trait |
Thallium 201 uptake study of thyroid |
Radionuclide imaging of thyroid using thallium-201 |
cacao |
Cocoa (substance) |
cacao |
Cacao tree |
Theophylline + dextrose |
Product containing theophylline (medicinal product) |
Theophylline 10mg/5mL s/f oral solution |
Theophylline 2 mg/mL oral solution |
Theophylline 125mg capsule |
Theophylline 125 mg prolonged-release oral capsule |
Theophylline 125mg m/r capsule |
Theophylline 125 mg prolonged-release oral capsule |
Theophylline 175mg m/r tablet |
Product containing precisely theophylline 175 milligram/1 each prolonged-release oral tablet (clinical drug) |
Theophylline 200mg |
Theophylline 200 mg prolonged-release oral tablet |
Theophylline 200mg m/r tablet |
Theophylline 200 mg prolonged-release oral tablet |
Theophylline 250mg capsule |
Product containing precisely theophylline 250 milligram/1 each prolonged-release oral capsule (clinical drug) |
Theophylline 250mg m/r capsule |
Product containing precisely theophylline 250 milligram/1 each prolonged-release oral capsule (clinical drug) |
Theophylline 250mg m/r tablet |
Product containing precisely theophylline 250 milligram/1 each prolonged-release oral tablet (clinical drug) |
Theophylline 300mg capsule |
Theophylline 300 mg prolonged-release oral capsule |
Theophylline 300mg m/r capsule |
Theophylline 300 mg prolonged-release oral capsule |
Theophylline 300mg m/r tablet |
Theophylline 300 mg prolonged-release oral tablet |
Theophylline 400mg m/r tablet |
Product containing precisely theophylline 400 milligram/1 each prolonged-release oral tablet (clinical drug) |
Theophylline 60mg m/r capsule |
Product containing precisely theophylline 60 milligram/1 each prolonged-release oral capsule (clinical drug) |
Theophylline measurement |
Aminophylline measurement (procedure) |
Theophylline measurement |
Theophylline measurement |
Therapeutic abortion procedure |
Termination of pregnancy (procedure) |
Therapeutic abortion procedure |
Therapeutic abortion procedure (procedure) |
Therapeutic asp.: gastrointestinal tract/CVS/RS (procedure) |
Therapeutic aspiration procedure |
Therapeutic asp: tracheostomy |
Therapeutic suctioning of trachea via tracheostomy (procedure) |